ENTITY
Regeneron Pharmaceuticals

Regeneron Pharmaceuticals (REGN US)

128
Analysis
Health CareUnited States
Regeneron Pharmaceuticals, Inc. is a biopharmaceutical company that discovers, develops, and commercializes pharmaceutical products for the treatment of serious medical conditions. The Company has therapeutic candidates in clinical trials for the potential treatment of cancer, eye diseases, and inflammatory diseases, and has preclinical programs in other diseases and disorders.
more
bearishS&P 500 INDEX
19 Mar 2020 19:56

S&P 500 Technical Appraisal and Support Levels

S&P 500 Potential Support Levels. Current logical support levels we are monitoring include the December 2018 low of 2,346 and prior resistance...

Logo
420 Views
Share
bullishS&P 500 INDEX
28 Nov 2019 06:30

U.S. Equity Strategy: Upgrading Health Care to Overweight

Ongoing bullish developments continue to support our belief that we are in the early stages of a broad-based advance following a nearly 2-year...

Logo
379 Views
Share
28 Feb 2019 04:23

Amarin Q4 2018 Conference Call--Strong Sales & High Confidence

Q4 2018 Revenues Stronger Than Pre-Announcement on January 4th: Amarin released its Q4 2018 results today and held a conference call. Results of...

Logo
689 Views
Share
bearishS&P 500 INDEX
09 Jan 2019 03:12

U.S. Equity Strategy: Oversold Rally Continues

A combination of, optimism surrounding U.S.-China trade talks, and Fed Chairman Powell’s comments have led to a continuation of the oversold bounce...

Logo
580 Views
Share
bullishS&P 500 INDEX
29 Aug 2018 21:32

Technically Attractive U.S. Stocks for Value Investors

Key points: Energy names are showing signs of bottoming with the recent uptick in crude, and weakness in the U.S. dollar REITs are continuing to...

Logo
461 Views
Share
x